MDT

82.52

-3.52%↓

A

121.43

+0.22%↑

VEEV

167.92

-0.73%↓

HQY

84.82

-1.52%↓

NEOG

9.35

-2.5%↓

MDT

82.52

-3.52%↓

A

121.43

+0.22%↑

VEEV

167.92

-0.73%↓

HQY

84.82

-1.52%↓

NEOG

9.35

-2.5%↓

MDT

82.52

-3.52%↓

A

121.43

+0.22%↑

VEEV

167.92

-0.73%↓

HQY

84.82

-1.52%↓

NEOG

9.35

-2.5%↓

MDT

82.52

-3.52%↓

A

121.43

+0.22%↑

VEEV

167.92

-0.73%↓

HQY

84.82

-1.52%↓

NEOG

9.35

-2.5%↓

MDT

82.52

-3.52%↓

A

121.43

+0.22%↑

VEEV

167.92

-0.73%↓

HQY

84.82

-1.52%↓

NEOG

9.35

-2.5%↓

Search

Pulse Biosciences Inc

Avatud

SektorTervishoid

23.93 2.31

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

23.37

Max

24.09

Põhinäitajad

By Trading Economics

Sissetulek

2M

-17M

Müük

178K

264K

Aktsiakasum

-0.18

Kasumimarginaal

-6,603.409

Töötajad

116

EBITDA

2M

-17M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+28.21% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2026

Turustatistika

By TradingEconomics

Turukapital

328M

1.3B

Eelmine avamishind

21.62

Eelmine sulgemishind

23.93

Uudiste sentiment

By Acuity

50%

50%

159 / 348 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. apr 2026, 23:49 UTC

Uudisväärsed sündmused

New Zealand 1Q Inflation Higher Than Expected

20. apr 2026, 23:10 UTC

Kuumad aktsiad

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20. apr 2026, 22:53 UTC

Suurimad hinnamuutused turgudel

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20. apr 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20. apr 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20. apr 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20. apr 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. apr 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20. apr 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20. apr 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20. apr 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20. apr 2026, 22:26 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Aims for Acquisition to Be Completed by End-2026

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20. apr 2026, 22:25 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Acquisition Would Be for A$175 Million

20. apr 2026, 22:24 UTC

Omandamised, ülevõtmised, äriostud

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20. apr 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20. apr 2026, 22:01 UTC

Omandamised, ülevõtmised, äriostud

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20. apr 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20. apr 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20. apr 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20. apr 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20. apr 2026, 21:13 UTC

Tulu

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20. apr 2026, 21:10 UTC

Tulu

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20. apr 2026, 21:09 UTC

Tulu

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20. apr 2026, 21:08 UTC

Tulu

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20. apr 2026, 21:07 UTC

Tulu

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20. apr 2026, 21:05 UTC

Tulu

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20. apr 2026, 21:05 UTC

Tulu

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

28.21% tõus

12 kuu keskmine prognoos

Keskmine 30 USD  28.21%

Kõrge 30 USD

Madal 30 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

159 / 348 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat